retatrutide liver damage STUDY: Novel “Triagonist” Resolved Steatosis in Over 85% of Patients with MASLD and Obesity Retatrutide vs Tirzepatide: Which Weight-Loss

Incretin-based drugs and risk of lung cancer among individuals with type 2 diabetes

Contraindications include personal or family history of medullary thyroid carcinoma, MEN2 syndrome, acute pancreatitis, or severe renal impairment

Aggressive protocols: 8 to 12 mg/week for maximum weight loss

Common effects may include gastrointestinal symptoms such as nausea, particularly during dose titration

Importantly, these inconsistencies may reflect methodological limitations rather than biological absence

Patients on GLP-1RAs are considered at-risk, meaning they also should: Follow more frequent reexamination intervals Receive individualized risk counseling regarding ocular risks Get collaborative care with providers managing their diabetes and other systemic conditions Doctors of optometry have to be aware, Dr